Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exagen (XGN) Return on Invested Capital (2019 - 2025)

Exagen (XGN) has disclosed Return on Invested Capital for 5 consecutive years, with 0.35% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Invested Capital changed N/A year-over-year to 0.35%, compared with a TTM value of 0.35% through Dec 2025, changed N/A, and an annual FY2025 reading of 0.41%, down 2.0% over the prior year.
  • Return on Invested Capital was 0.35% for Q4 2025 at Exagen, down from 0.3% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.14% in Q2 2021 and bottomed at 0.44% in Q3 2024.
  • Average Return on Invested Capital over 3 years is 0.27%, with a median of 0.25% recorded in 2021.
  • The sharpest move saw Return on Invested Capital changed 0bps in 2021, then grew 14bps in 2025.
  • Year by year, Return on Invested Capital stood at 0.21% in 2021, then tumbled by -109bps to 0.44% in 2024, then increased by 21bps to 0.35% in 2025.
  • Business Quant data shows Return on Invested Capital for XGN at 0.35% in Q4 2025, 0.3% in Q3 2025, and 0.44% in Q3 2024.